Coronary CTA specific definitions of high-risk plaque features optimized for the detection of ACS: results from the ROMICAT II trial
30 August 2016 (11:09 - 11:18)
Organised by:
Abstract
About the speaker

University Hospital Augsburg, Augsburg (Germany)
9 More presentations in this session

Doctor A. Silva Ferreira (Lisbon, PT)

Associate Professor A. Arbab-Zadeh (Baltimore, US)
Access the full session
The Event
ESC Congress 2016
30 August 2016
11:09 CET



